BN

Birendra Narain Srivastava

Active Director Director DIN 10126245
DIN 10126245 First appointment Apr 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Birendra Narain Srivastava

Data last updated:

Birendra Narain Srivastava is a Director at Cuido Pharmaceuticals Private Limited (since 2023). The company operates in Pharma.

DIN 10126245
Primary Designation Director
Industry Pharma
First Appointment 20 Apr 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Apr 20232023Active

Board colleagues of Birendra Narain Srivastava

NameDINCompanyDesignation
Minakshi Shrivastava10126246Cuido Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cuido Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Birendra Narain Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Birendra Narain Srivastava

Birendra Narain Srivastava currently holds 1 directorship: Cuido Pharmaceuticals Private Limited (Director, since 20 Apr 2023).

Birendra Narain Srivastava was first appointed on 20 Apr 2023 as Director at Cuido Pharmaceuticals Private Limited.

The current boards of Birendra Narain Srivastava's companies include Minakshi Shrivastava (Cuido Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available